- Record: found
- Abstract: found
- Article: not found
Two-year outcomes after transcatheter or surgical aortic-valve replacement.
Susheel K Kodali
1 ,
Mathew R Williams ,
Craig R Smith ,
Lars G Svensson ,
John G Webb ,
Raj R Makkar ,
Gregory P Fontana ,
Todd M Dewey ,
Vinod H Thourani ,
Augusto D Pichard ,
Michael Fischbein ,
Wilson Y Szeto ,
Scott Lim ,
Kevin L Greason ,
Paul S Teirstein ,
S Chris Malaisrie ,
Pamela S Douglas ,
Rebecca T Hahn ,
Brian Whisenant ,
Alan Zajarias ,
Duolao Wang ,
Jodi J Akin ,
William N Anderson ,
Martin B Leon
May 03 2012
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that among high-risk patients with aortic stenosis, the 1-year survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical replacement. However, longer-term follow-up is necessary to determine whether TAVR has prolonged benefits.